Bank of the James Reports Record Quarterly Earnings and Margin ExpansionLoan Growth, Stable Funding Costs, and Exceptional Asset Quality Drive Record Profitability LYNCHBURG, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the James (the “Bank”), a full-service commercial and retail bank, and Pettyjohn, Wood & White, Inc. (“PWW”), an SEC-registered investment advisor, today announced unaudited results of operations f ...

Châtillon, France, October 30, 2025 DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Market: DBVT), (the “Company” or “DBV”), a clinical-stage biopharmaceutical company, today announced the provisional appointment of a new independent director, Dr. Philina Lee, to its Board of Directors (the “Board”), effective October 30, 2025. Dr. Lee is appointed in replacement of Daniel Soland, subject to the ratification by ...

LYNCHBURG, Va., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Bank of the James Financial Group, Inc. (the “Company”) (NASDAQ:BOTJ), the parent company of Bank of the James (the “Bank”), a full-service commercial and retail bank, and Pettyjohn, Wood & White, Inc. (“PWW”), an SEC-registered investment advisor, today announced changes to the Bank’s executive leadership to improve oversight and better coordinate financial and investment approaches. J. Todd Scruggs, currently serving as Chief Financial Officer, will transi ...

Call to Be Held Wednesday, November 19, 2025 at 4:30 PM ETWALTHAM, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM), a leader in digital manufacturing solutions, today announced it will host a conference call and webcast to discuss its Q3 2025 financial results for the period ended September 30, 2025. Conference Call Information Date: Wednesday, November 19, 2025Time: 4:30 pm ET Pre-Registration Link for Dial-In AccessParticipants can pre-register for the conference call here in o ...

SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, today announced it will present a trial-in-progress poster for the Phase 3 OPERA-02 trial at the 2025 San Antonio Breast Cancer Symposium (SABCS 2025) taking place December 9-12, 2025 in San Antonio, TX. The trial is evaluating palaze ...

New whitepaper demonstrates how CA enables primary care teams in resource-constrained settings to prevent, detect, and manage chronic disease.SAN FRANCISCO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Counterpart Health, Inc. (“Counterpart”), a wholly owned subsidiary of Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”) and a leading AI-powered physician-enablement platform, today released a whitepaper demonstrating how Counterpart Assistant (CA) technology supports value‑ba ...

Fairchild Completes a Nevada Trinity with Acquisition of Advanced Stage Carlin Queen Project Figure 1 - Carlin Queen Project VANCOUVER, B.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- via IBN – Fairchild Gold Corp. (“Fairchild” or the “Company”) (TSXV: FAIR, Frankfurt: Y4Y, OTCID: FCHDF), is pleased to announce that it has entered into a Binding Purchase Agreement (“BPA”) dated October 30th , 2025, with a private arm’s length party, to acquire a 100% interest in the drill-ready Carlin Queen gold and silver prop ...

公司财务业绩 - 公司公布2025财年第三季度（截至2025年9月30日的三个月）财务业绩 [1] 公司战略定位 - 公司是全球最大的企业比特币持有者和全球首家比特币国库公司 [1] - 在第三季度及进入十月份，公司继续巩固其作为全球领先比特币国库公司的地位 [1] - 公司在第三季度增加了其比特币持有量 [1] 公司股票信息 - 公司名称为Strategy Inc，在纳斯达克以多种代码交易（STRF/STRC/STRK/STRD/MSTR） [1]

SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients with devastating autoimmune diseases and cancers, announced today that management will participate at the following investor conferences: TD Cowen's Immunology & Inflammation Summit (Virtual) - fireside chat on Wednesday, November 12, 2025, at 11:30 a.m. ET 2025 Jefferies Global Healthcare Conf ...

NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- FTAI Infrastructure Inc. (NASDAQ:FIP) (the “Company” or “FTAI Infrastructure”) today reported financial results for the third quarter 2025. The Company’s consolidated comparative financial statements and key performance measures are attached as an exhibit to this press release. Business Highlights Reported $70.9 million of Adjusted EBITDA, up 54% from the second quarter of 2025.Closed the acquisition of the Wheeling & Lake Erie Railway into a voting trust on Augus ...